Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

10x Genomics (TXG) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to -$2.5 million.

  • 10x Genomics' Other Non Operating Income rose 1656.28% to -$2.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 million, marking a year-over-year increase of 14983.07%. This contributed to the annual value of $1.0 million for FY2025, which is 14983.07% up from last year.
  • According to the latest figures from Q4 2025, 10x Genomics' Other Non Operating Income is -$2.5 million, which was up 1656.28% from -$1.2 million recorded in Q3 2025.
  • 10x Genomics' 5-year Other Non Operating Income high stood at $4.0 million for Q4 2022, and its period low was -$3.0 million during Q4 2024.
  • Over the past 5 years, 10x Genomics' median Other Non Operating Income value was -$664000.0 (recorded in 2021), while the average stood at -$116150.0.
  • Examining YoY changes over the last 5 years, 10x Genomics' Other Non Operating Income showed a top increase of 7980000.0% in 2022 and a maximum decrease of 45374.28% in 2022.
  • Over the past 5 years, 10x Genomics' Other Non Operating Income (Quarter) stood at $5000.0 in 2021, then surged by 79800.0% to $4.0 million in 2022, then dropped by 0.33% to $4.0 million in 2023, then crashed by 176.57% to -$3.0 million in 2024, then increased by 16.56% to -$2.5 million in 2025.
  • Its Other Non Operating Income stands at -$2.5 million for Q4 2025, versus -$1.2 million for Q3 2025 and $2.6 million for Q2 2025.